Adherium Ltd (ADR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 9.437x

Based on the latest financial reports, Adherium Ltd (ADR) has a cash flow conversion efficiency ratio of 9.437x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.43 Million ≈ $-5.26 Million USD) by net assets (AU$-787.24K ≈ $-557.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ADR defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Adherium Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adherium Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Adherium Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adherium Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Readcloud Ltd
AU:RCL
-0.153x
Raj Oil Mills Limited
NSE:ROML
1.915x
TCM Corporation Public Company Limited
BK:TCMC
0.321x
Richy Place 2002 Public Company Limited
BK:RICHY
0.031x
GLG Corp Ltd
AU:GLE
0.125x
Tribe Property Technologies Inc
V:TRBE
-0.229x
Siamraj Public Company Limited
BK:SR
0.026x
Paras Petrofils Limited
NSE:PARASPETRO
N/A

Annual Cash Flow Conversion Efficiency for Adherium Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adherium Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see ADR stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-4.76 Million
≈ $-3.37 Million
AU$-9.98 Million
≈ $-7.06 Million
2.096x +227.98%
2024-06-30 AU$6.48 Million
≈ $4.59 Million
AU$-10.61 Million
≈ $-7.51 Million
-1.638x -62.64%
2023-06-30 AU$9.21 Million
≈ $6.52 Million
AU$-9.28 Million
≈ $-6.56 Million
-1.007x +41.98%
2022-06-30 AU$5.54 Million
≈ $3.92 Million
AU$-9.61 Million
≈ $-6.80 Million
-1.736x -116.08%
2021-06-30 AU$14.04 Million
≈ $9.93 Million
AU$-11.27 Million
≈ $-7.98 Million
-0.803x +62.85%
2020-06-30 AU$3.38 Million
≈ $2.39 Million
AU$-7.32 Million
≈ $-5.18 Million
-2.162x +84.80%
2019-06-30 AU$830.00K
≈ $587.28K
AU$-11.81 Million
≈ $-8.35 Million
-14.225x -1754.91%
2018-06-30 AU$12.81 Million
≈ $9.06 Million
AU$-9.82 Million
≈ $-6.95 Million
-0.767x -50.35%
2017-06-30 AU$22.70 Million
≈ $16.07 Million
AU$-11.58 Million
≈ $-8.19 Million
-0.510x -76.99%
2016-06-30 AU$27.46 Million
≈ $19.43 Million
AU$-7.91 Million
≈ $-5.60 Million
-0.288x -43364.50%
2015-06-30 AU$34.53 Million
≈ $24.43 Million
AU$23.00K
≈ $16.27K
0.001x +100.07%
2014-06-30 AU$2.17 Million
≈ $1.53 Million
AU$-2.16 Million
≈ $-1.53 Million
-0.998x +0.00%
2014-03-31 AU$2.31 Million
≈ $1.64 Million
AU$-2.31 Million
≈ $-1.63 Million
-0.998x -24548.25%
2013-06-30 AU$3.50 Million
≈ $2.48 Million
AU$-14.19K
≈ $-10.04K
-0.004x --

About Adherium Ltd

AU:ADR Australia Medical Devices
Market Cap
$7.60 Million
AU$10.75 Million AUD
Market Cap Rank
#27678 Global
#1408 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$10.31
About

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more